Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.744 USD | -2.26% | +0.06% | -18.26% |
01/04 | Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
26/01 | Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Rule | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-18.26% | 63.08L | |
+29.72% | 68TCr | |
+30.34% | 57TCr | |
-4.06% | 36TCr | |
+17.95% | 33TCr | |
+3.95% | 28TCr | |
+16.21% | 24TCr | |
+9.66% | 21TCr | |
-6.83% | 20TCr | |
+6.77% | 17TCr |
- Stock Market
- Equities
- TTNP Stock
- News Titan Pharmaceuticals, Inc.
- Titan Pharmaceuticals : Maxim Group Upgrades Titan Pharmaceuticals to Buy From Hold, $11 Price Target